Sansure Biotech Inc. (688289.SH) has obtained a medical device registration certificate for its products.

Sansure Biotech Inc. (688289.SH) announced that its product, the human papillomavirus nucleic acid detection kit (PCR-fluorescent probe method), recently received the "Medical Device Change Registration (Filing) Document" issued by the National Medical Products Administration, and has officially been approved for the addition of cervical cancer primary screening, cervical cancer combined screening, and ASCUS population triage expected uses.